Companies / France
Research-based Drugmakers Feel The Pinch
March 2007 | Industry NewsIt was a tough year in 2006 for France's leading drugmakers, as government cost-cutting measures bit deeply into revenues. Although, the drug market expanded by 4%, this is lower than the growth witnessed over the last fifteen years, which stood consistently between 5%-7%. Also, the authorities are encouraging generic drugs, which grew by 15% in 2006, placing pressure on brand name medicines, and disproportionately affecting research-based
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
